Determining a Worldwide Prevalence of Oculocutaneous Albinism: A Systematic Review.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
03 Jul 2023
Historique:
medline: 17 7 2023
pubmed: 13 7 2023
entrez: 13 7 2023
Statut: ppublish

Résumé

The aim of this systematic review was to investigate the available data on the epidemiology of oculocutaneous albinism (OCA) around the world, and to determine whether a generalizable, worldwide prevalence figure could be proposed. Extensive literature search strategies were conducted, interrogating PubMed, Scopus, and Web of Science, to locate relevant literature. Ultimately 34 studies reporting original data were included for analysis. Findings showed that most data were outdated, and only 6 of 34 articles (18%) were published after 2010. There were few good studies with sound methodology and large, clearly defined population samples. Only a small proportion of countries worldwide (26/193 [13%]) have produced prevalence figures for OCA. By continent, African studies were disproportionately represented (15/34 [44%]). The highest prevalence rates (range, 1 in 22 to 1 in 1300; mean, 1 in 464) were reported in population isolates. The mean prevalence from four African countries was 1 in 4264 (range, 1 in 1755 to 1 in 7900). Prevalence for three countries in Europe (mean, 1 in 12,000; range, 1 in 10,000 to 1 in 15,000) may be underestimated, as the phenotype, in fair-skinned populations, may be missed or misdiagnosed as ocular albinism or isolated visual impairment. Population rates may vary depending on local cultural factors (e.g., consanguineous matings) and may change over time. The prevalence of OCA varies widely between continents and population groups, and it is often influenced by local factors. It was not possible, therefore, to determine a single, generalizable worldwide prevalence rate for OCA, although continental rates for Africa and Europe are useful.

Identifiants

pubmed: 37440261
pii: 2791301
doi: 10.1167/iovs.64.10.14
pmc: PMC10353740
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14

Références

Coll Antropol. 2013 Sep;37(3):723-34
pubmed: 24308209
Ann Hum Genet. 1960 Jul;24:213-38
pubmed: 13825323
Br J Dermatol. 1975 May;92(5):485-92
pubmed: 1174464
Clin Genet. 1987 Apr;31(4):228-42
pubmed: 3109790
Clin Genet. 1989 Jul;36(1):43-52
pubmed: 2766562
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
J Hered. 1964 May-Jun;55:115-20
pubmed: 14170400
Ann Hum Biol. 2007 Jul-Aug;34(4):493-7
pubmed: 17620156
Clin Genet. 1976 Jan;9(1):77-80
pubmed: 1248166
Natl Cancer Inst Monogr. 1963 Mar;11:197-214
pubmed: 14014027
Br J Ophthalmol. 2014 Jul;98(7):990
pubmed: 24671927
Orphanet J Rare Dis. 2007 Nov 02;2:43
pubmed: 17980020
J Med Genet. 1995 Nov;32(11):859-61
pubmed: 8592327
J Community Genet. 2013 Jul;4(3):391-7
pubmed: 23821042
Am J Hum Genet. 1949 Dec;1(2):156-78
pubmed: 17948392
Am J Hum Genet. 2003 Jan;72(1):62-72
pubmed: 12469324
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Am J Hum Genet. 1965 Jan;17:23-35
pubmed: 14255554
BMC Public Health. 2006 Aug 17;6:212
pubmed: 16916463
J Med Genet. 1992 Jul;29(7):483-6
pubmed: 1640427
J Hum Genet. 2010 Feb;55(2):103-11
pubmed: 20019752
J Med Genet. 1997 Sep;34(9):733-5
pubmed: 9321758
Afr J Disabil. 2022 Oct 14;11:877
pubmed: 36353393
J Invest Dermatol. 2020 Jul;140(7):1449-1451
pubmed: 31883962
Am J Phys Anthropol. 1946 Dec;4(4):483-90
pubmed: 20281561
Rev Epidemiol Sante Publique. 1980 Apr 30;28(1):81-8
pubmed: 7465914
Hum Hered. 1978;28(6):401-10
pubmed: 680702
J Dermatol Sci. 2006 May;42(2):121-4
pubmed: 16517127
Cancer. 1985 Apr 15;55(8):1823-8
pubmed: 3978567
S Afr Med J. 1982 Mar 13;61(11):383-6
pubmed: 7064008
Ophthalmology. 2018 Dec;125(12):1953-1960
pubmed: 30098354
Optom Vis Sci. 2009 Jun;86(6):659-62
pubmed: 19390472
Ophthalmic Paediatr Genet. 1990 Dec;11(4):255-63
pubmed: 2096353
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1058-64
pubmed: 19060277
Am J Hum Genet. 1970 Jan;22(1):55-74
pubmed: 4983623
J Biosoc Sci. 1974;6(1):107-12
pubmed: 4828335
Yi Chuan Xue Bao. 1994;21(3):169-72
pubmed: 7917429
Ann Hum Genet. 1961 Oct;25:123-30
pubmed: 14496533
Eur J Hum Genet. 2021 Oct;29(10):1577-1583
pubmed: 33504991
Ann Eugen. 1952 Aug;17(Part 1):38-73
pubmed: 12976942
J Med Genet. 1996 Aug;33(8):641-4
pubmed: 8863154
Int J Technol Assess Health Care. 2015 Jan;31(1-2):51-3
pubmed: 25989817
S Afr Med J. 1974 Nov 23;48(57):2345-7
pubmed: 4432185
Science. 1969 Apr 4;164(3875):30-7
pubmed: 5773710
Am J Hum Genet. 1995 Mar;56(3):586-91
pubmed: 7887411

Auteurs

Jennifer G R Kromberg (JGR)

Division of Human Genetics, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Kaitlyn A Flynn (KA)

Division of Human Genetics, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Robyn A Kerr (RA)

Division of Human Genetics, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH